Emerging New Agents for the Management of Patients with Non-Small Cell Lung Cancer

@article{Capelletto2012EmergingNA,
  title={Emerging New Agents for the Management of Patients with Non-Small Cell Lung Cancer},
  author={Enrica Capelletto and Prof. Silvia Novello},
  journal={Drugs},
  year={2012},
  volume={72},
  pages={37-52}
}
Lung cancer is one of the leading causes of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for at least 87% of all lung cancers and most cases present at an advanced stage, with metastatic, locally advanced or recurrent disease. With a greater understanding of tumour biology, a number of targeted agents have been investigated for the treatment of advanced NSCLC. These include insulin-like growth factor inhibitors, c-MET inhibitors, poly(adenosine diphosphate-ribose… CONTINUE READING